ada guidelines pregnancy glp-1 receptor agonist discontinue before conception Taking GLP-1s during the first trimester of does not appear to substantially increase the risk of adverse outcomes AJOG Expert Review: Glucagon-like peptide-1
Description
The problem is what the studies actually show.
Visit Us!

Evidence is emerging that glucagon-like peptide-1 (GLP-1) receptor agonists have anti-inflammatory and chondroprotective properties independent of their effects on weight loss

CAS Number: 2381089-83-2

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence
Curious about GLP-1 medications like Ozempic and Wegovy
